[Dublin, IRELAND] – Global animal health and nutrition company Alltech, is pleased to announce that several human health claims relating to Sel-Plex® have been accepted by the European Food Safety Authority (EFSA).
The EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)2 has accepted health claims linking the dietary intake of Sel-Plex to: “protection of DNA, proteins and lipids from oxidative damage, normal function of the immune system, normal thyroid function and normal spermatogenesis.”
Sel-Plex, from Alltech, is the only FDA reviewed form of organic selenium, and is the first strain specific form of organic selenium to be EU approved for all animal species (Strain: Saccharomyces cerevisiae CNCM I-3060). Selenium is an essential nutrient for both animals and people, and plays a critical role in metabolism, normal growth, reproductive health, and immunity. Because of its specific organic form, Sel-Plex is better absorbed and retained by the animal.
Marc Larousse, vice president, Alltech Europe, says: “Alltech has been the sole leader in submitting extensive data and research petitioning EFSA for this successful opinion for Sel-Plex. This positive opinion by EFSA confirms the role that Sel-Plex plays in human nutrition. It further underlines the significance Sel-Plex has in the full food chain from the animal to the human. We are pleased with the acceptance from EFSA; Alltech is committed to its pioneering role utilising nutrigenomics and gene expression profiling as an effective tool for improving nutritional strategies in both animals and humans.”